Added to YB: 2024-09-30
Pitch date: 2024-09-28
INGN [bearish]
Inogen, Inc.
+39.77%
current return
Author Info
No bio for this author
Company Info
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
Market Cap
$156.4M
Pitch Price
$9.68
Price Target
N/A
Dividend
N/A
EV/EBITDA
-8.60
P/E
-5.85
EV/Sales
0.15
Sector
Health Care Equipment and Supplies
Category
special_situation
Inogen: The case of dangerous Oxygen
INGN short: Oxygen concentrator safety concerns with 111 adverse events since 2020, including hospitalizations & deaths. FDA MAUDE data shows 69 malfunctions, 44 injuries, 2 deaths in 2024. Muddy Waters exposed TAM misrepresentation. 15% of 2024 oxygenic adverse events from Inogen. Safety profile worse than comparables.
Read full article (8 min)